Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

NCT02887625 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

410

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Pioglitazone plus exenatide
DRUG: insulin glargine and insulin aspart

Sponsor

Dr. Muhammad Abdulghani